Location: PALO ALTO, CA
CIK: 0001839948 · Show all filings
Period: Q1 2026 (← Previous)
Filing Date: May 15, 2026
Total Value: $3.495B (100.0% shares, 0.0% debt)
| Ticker | Issuer | Shares | Value | % | Est. Cost | Unrealized | Class | CUSIP |
|---|---|---|---|---|---|---|---|---|
| BCRX | BIOCRYST PHARMACEUTICALS INC | 11,020,968 | $105M | 3.0% | — | — | COMM | 09058V103 |
| VOR | VOR BIOPHARMA INC | 5,673,078 | $96.5M | 2.8% | — | — | COMM | 929033207 |
| IRON | DISC MEDICINE INC | 1,341,862 | $85.8M | 2.5% | — | — | COMM | 254604101 |
| SRZN | SURROZEN INC | 1,473,101 | $42.91M | 1.2% | — | — | COMM | 86889P208 |
| IPSC | CENTURY THERAPEUTICS INC | 17,754,430 | $39.02M | 1.1% | — | — | COMM | 15673T100 |
| TECX | TECTONIC THERAPEUTIC INC | 1,204,891 | $37.24M | 1.1% | — | — | COMM | 878972108 |
| CATX | PERSPECTIVE THERAPEUTICS INC | 7,915,567 | $33.01M | 0.9% | — | — | COMM | 46489V302 |
| ALXO | ALX ONCOLOGY HOLDINGS INC | 13,011,849 | $26.09M | 0.7% | — | — | COMM | 00166B105 |
| AGMB | AGOMAB THERAPEUTICS NV | 2,053,233 | $21.54M | 0.6% | — | — | ADRS | 00860C102 |
| CNTX | CONTEXT THERAPEUTICS INC | 2,682,696 | $7.029M | 0.2% | — | — | COMM | 21077P108 |
| CGEM | CULLINAN THERAPEUTICS INC | 406,786 | $5.78M | 0.2% | — | — | COMM | 230031106 |
| Ticker | Issuer | Shares | Value | % | Est. Cost | Unrealized | Class | CUSIP |
|---|---|---|---|---|---|---|---|---|
| MIRM | MIRUM PHARMACEUTICALS INC | 1,062,049 (+1611.6%) | $98.11M (+1901.8%) | 2.8% | — | — | COMM | 604749101 |
| IMVT | IMMUNOVANT INC | 4,457,988 (+168.4%) | $111M (+162.3%) | 3.2% | — | — | COMM | 45258J102 |
| TYRA | TYRA BIOSCIENCES INC | 3,248,980 (+12.1%) | $124M (+63.3%) | 3.6% | — | — | COMM | 90240B106 |
| RVMD | REVOLUTION MEDICINES INC | 576,473 (+32.1%) | $56.06M (+61.3%) | 1.6% | — | — | COMM | 76155X100 |
| RLAY | RELAY THERAPEUTICS INC | 4,273,356 (+32.7%) | $42.52M (+56.1%) | 1.2% | — | — | COMM | 75943R102 |
| TRDA | ENTRADA THERAPEUTICS INC | 2,287,500 (+9.5%) | $28.87M (+34.5%) | 0.8% | — | — | COMM | 29384C108 |
| LBRX | LB PHARMACEUTICALS INC | 1,839,489 (+5.4%) | $45.28M (+16.6%) | 1.3% | — | — | COMM | 50180M108 |
| AVTX | AVALO THERAPEUTICS INC | 738,383 (+52.9%) | $11.02M (+25.7%) | 0.3% | — | — | COMM | 05338F306 |
| Ticker | Issuer | Shares | Value | % | Est. Cost | Unrealized | Class | CUSIP |
|---|---|---|---|---|---|---|---|---|
| RAPT | RAPT THERAPEUTICS INC | 2,582,408 | $87.47M | 2.5% | — | — | — | 75382E208 |
| EYPT | EYEPOINT PHARMACEUTICALS INC | 3,572,335 | $65.27M | 1.9% | — | — | — | 30233G209 |
| AGIO | AGIOS PHARMACEUTICALS INC | 1,181,841 | $32.17M | 0.9% | — | — | — | 00847X104 |
| MAZE | MAZE THERAPEUTICS INC | 173,816 | $7.201M | 0.2% | — | — | — | 578784100 |
| VTYX | VENTYX BIOSCIENCES INC | 316,195 | $2.855M | 0.1% | — | — | — | 92332V107 |
| Ticker | Issuer | Shares | Value | % | Est. Cost | Unrealized | Class | CUSIP |
|---|---|---|---|---|---|---|---|---|
| ABVX | ABIVAX SA AMERICAN DEPOSITARY SHARES | 6,481,085 (-8.9%) | $722M (-24.8%) | 20.6% | — | — | ADRS | 00370M103 |
| TNGX | TANGO THERAPEUTICS INC | 10,531,071 (-17.5%) | $220M (+94.8%) | 6.3% | — | — | COMM | 87583X109 |
| GPCR | STRUCTURE THERAPEUTICS INC | 140,411 (-84.8%) | $6.768M (-89.4%) | 0.2% | — | — | ADRS | 86366E106 |
| OCUL | OCULAR THERAPEUTIX INC | 1,647,752 (-71.3%) | $13.96M (-80.0%) | 0.4% | — | — | COMM | 67576A100 |
| LQDA | LIQUIDIA TECHNOLOGIES INC | 403,048 (-76.4%) | $15.21M (-74.2%) | 0.4% | — | — | COMM | 53635D202 |
| UPB | UPSTREAM BIO INC | 181,063 (-75.7%) | $1.63M (-91.9%) | 0.0% | — | — | COMM | 91678A107 |
| COGT | COGENT BIOSCIENCES INC | 4,946,894 (-15.7%) | $190M (-8.7%) | 5.4% | — | — | COMM | 19240Q201 |
| URGN | UROGEN PHARMA LTD | 405,365 (-43.5%) | $7.288M (-56.6%) | 0.2% | — | — | COMM | M96088105 |
| ARVN | ARVINAS HOLDING CO LLC | 2,387,461 (-10.5%) | $25.31M (-20.0%) | 0.7% | — | — | COMM | 04335A105 |
| MNPR | MONOPAR THERAPEUTICS INC | 132,103 (-6.9%) | $7.238M (-21.9%) | 0.2% | — | — | COMM | 61023L207 |
| Ticker | Issuer | Shares | Value | % | Est. Cost | Unrealized | Class | CUSIP |
|---|---|---|---|---|---|---|---|---|
| CGON | CG ONCOLOGY INC | 3,670,206 | $248M | 7.1% | — | — | COMM | 156944100 |
| DNTH | DIANTHUS THERAPEUTICS INC | 1,676,624 | $141M | 4.0% | — | — | COMM | 252828108 |
| CNTA | CENTESSA PHARMACEUTICALS PLC | 4,286,480 | $170M | 4.9% | — | — | ADRS | 152309100 |
| SYRE | SPYRE THERAPEUTICS INC | 1,900,582 | $95.87M | 2.7% | — | — | COMM | 00773J202 |
| FULC | FULCRUM THERAPEUTICS INC | 5,250,000 | $40.27M | 1.2% | — | — | COMM | 359616109 |
| KOD | KODIAK SCIENCES INC | 1,445,538 | $55.1M | 1.6% | — | — | COMM | 50015M109 |
| BHVN | BIOHAVEN LTD | 4,631,317 | $39.18M | 1.1% | — | — | COMM | G1110E107 |
| AMLX | AMYLYX PHARMACEUTICALS INC | 6,243,812 | $86.79M | 2.5% | — | — | COMM | 03237H101 |
| XNCR | XENCOR INC | 2,452,138 | $29.57M | 0.8% | — | — | COMM | 98401F105 |
| SVRA | SAVARA INC | 12,362,205 | $67.5M | 1.9% | — | — | COMM | 805111101 |
| DYN | DYNE THERAPEUTICS INC | 4,615,144 | $83.67M | 2.4% | — | — | COMM | 26818M108 |
| ALEC | ALECTOR INC | 10,000,000 | $21.5M | 0.6% | — | — | COMM | 014442107 |
| GLUE | MONTE ROSA THERAPEUTICS INC | 4,622,151 | $76.03M | 2.2% | — | — | COMM | 61225M102 |
| ADCT | ADC THERAPEUTICS SA | 11,390,175 | $42.71M | 1.2% | — | — | COMM | H0036K147 |
| SLN | SILENCE THERAPEUTICS PLC | 3,033,560 | $15.99M | 0.5% | — | — | ADRS | 82686Q101 |
| KRRO | KORRO BIO INC | 416,301 | $4.713M | 0.1% | — | — | COMM | 500946108 |
| LONA | LEONABIO INC | 464,398 | $4.667M | 0.1% | — | — | COMM | 04746L203 |
| MBX | MBX BIOSCIENCES INC | 650,000 | $19.4M | 0.6% | — | — | COMM | 55287L101 |
| VTGN | VISTAGEN THERAPEUTICS INC | 2,676,580 | $1.53M | 0.0% | — | — | COMM | 92840H400 |
| JANX | JANUX THERAPEUTICS INC | 1,789,617 | $24.88M | 0.7% | — | — | COMM | 47103J105 |